Tenderwize
Back to tender search

Pharmaceutical supply contracts

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2028 · 622 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

35/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

35 / 100

Complexity

40 / 100

Risk factors

Absence of estimated value or framework maximum makes it impossible to gauge potential revenue or pricing expectations.

The notice explicitly states it is not subject to EU procurement directives or German competition law (Kartellvergabere...

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Jun 2028
  • Supply of pharmaceutical products for 5 specific active ingredients as defined in each lot.
  • Framework agreement with accession option, allowing additional parties to join the contract.
Show full summary

This is a framework agreement with accession option (Rahmenvertrag mit Beitrittsoption) for pharmaceutical products issued by BARMER, a German statutory health insurance company. It covers 5 lots for specific active ingredients: Bimatoprost, Calcipotriol + Betamethasone dipropionate, Eltrombopag (excluding SAA), Eltrombopag (Revolade®), and Nintedanib. The contract is structured as a 2-year framework (2026-06-01 to 2028-06-30) with a possible 3-month extension. The notice is not a public procurement under EU law and is published voluntarily. Estimated value is not provided. The procedure is open, and submissions must be electronic via the buyer's portal. The tender is in German only. No award criteria or selection criteria are specified in the available data.

Risks

Absence of estimated value or framework maximum makes it impossible to gauge potential revenue or pricing expectations.

The notice explicitly states it is not subject to EU procurement directives or German competition law (Kartellvergabere...

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Administrative

  • Tenders must be submitted electronically via the buyer's portal at Open portal
  • All documents must be in German; no other languages are accepted.
  • Maximum of 5 lots can be awarded and submitted.

Requirements may be incomplete.

Buyer

Location

Wuppertal, DEU

Identifier

992-80322-57

Activity

Health

Lots (5)

LOT-0001

Bimatoprost (MDO_0,1 mg_ml)

Framework agreement for pharmaceutical products containing Bimatoprost (MDO_0,1 mg/ml). The contract includes a once-only extension option of 3 months.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

May 2026 - Jun 2028

Category

Pharmaceutical products

Deadline

Deadline May 01, 2028

LOT-0002

Calcipotriol + Betamethason dipropionat (SCH)

Framework agreement for pharmaceutical products containing Calcipotriol and Betamethasone dipropionate (SCH). The contract includes a once-only extension option of 3 months.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

May 2026 - Jun 2028

Category

Pharmaceutical products

Deadline

Deadline May 01, 2028

LOT-0003

Eltrombopag (ausgenommen SAA)

Framework agreement for pharmaceutical products containing Eltrombopag (excluding SAA). The contract includes a once-only extension option of 3 months.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

May 2026 - Jun 2028

Category

Pharmaceutical products

Deadline

Deadline May 01, 2028

LOT-0004

Eltrombopag (Revolade®)

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

May 2026 - Jun 2028

Category

Pharmaceutical products

LOT-0005

Nintedanib

Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoffkombinationen enthalten.

SuppliesFrameworkEU fundedElectronic submission

Location

Wuppertal, Germany

Duration

May 2026 - Jun 2028

Category

Pharmaceutical products

Procurement Details

Publication date
13 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
252831-2026

Documents (1)

Similar tenders